
COULD THIS NEW NON-OPIOID COMPLETELY REPLACE FENTANYL? | EP 42
Discover the future of pain management on this episode of Atomic Anesthesia as we explore a major breakthrough: the FDA approval of suzetrigine, a first-in-class, nonopioid pain medication. Guided by ...
15 Juli 202512min
![PAIN PATHWAYS [WEBINAR REPLAY] | EP41](https://cdn.podme.com/podcast-images/E2F707EF1755CBCDD163763771468D98_small.jpg)
PAIN PATHWAYS [WEBINAR REPLAY] | EP41
In this live webinar, we discuss pain pathways in extreme detail, which is a foundational topic for anyone in anesthesia or in the ICU. We explore the four stages of pain—transduction, transmission, m...
30 Juni 20251h 14min

ANESTHESIA TECHNICIANS AND EFFECTIVE COLLABORATION WITH KERRIE KLEIN | EP40
In this episode, with CRNA Kerrie Klein, we discuss the essential but often misunderstood role of certified anesthesia technicians and technologists. We break down the differences between uncertified ...
23 Juni 202541min

EI/EQ AND LEADERSHIP WITH THERESA REED | EP39
In this episode, we discuss the crucial role emotional intelligence (EI) plays in the journey of becoming a CRNA. We explore what EI really means—understanding and managing your emotions and those of ...
16 Juni 202553min

PEDIATRIC EMERGENCIES WITH DR. MOTYKIEWICZ | EP38
In this episode, Pediatric CRNA Dr. Becky Motykiewicz dives into the most critical pediatric anesthesia complications you need to know—whether you're just starting out or already deep into practice. W...
29 Maj 202514min

MAKING SMART FINANCIAL DECISIONS AFTER CRNA SCHOOL | EP37
In this episode, Professor T discusses something at the top of everyone's minds when going to CRNA school - how am I going to pay for this?! We break down the smart, intentional decisions that made th...
23 Maj 202527min

SUGAMMADEX PHARMACOLOGY | EP35
In this episode, we dive into the game-changing drug sugammadex—a powerful agent that rapidly reverses neuromuscular blockade caused by rocuronium and vecuronium. We explore its unique mechanism of ac...
2 Maj 202519min





















